Our results suggest that the maintenance of stable BW and ‘healthy’ EAT‐myocardium microenvironment of the HF‐patients is associated with their ability to tolerate higher therapeutic doses of conventional therapeutics, namely neurohumoral inhibitors (ACE/ARB inhibitors and β‐adrenergic blockers). Here, ACE is linked to hydrops fetalis.